PT1100769E - Derivado do acido aminometilcarboxilico - Google Patents

Derivado do acido aminometilcarboxilico

Info

Publication number
PT1100769E
PT1100769E PT99939419T PT99939419T PT1100769E PT 1100769 E PT1100769 E PT 1100769E PT 99939419 T PT99939419 T PT 99939419T PT 99939419 T PT99939419 T PT 99939419T PT 1100769 E PT1100769 E PT 1100769E
Authority
PT
Portugal
Prior art keywords
aminometilcarboxylic
derived
acid
aminometilcarboxylic acid
Prior art date
Application number
PT99939419T
Other languages
English (en)
Inventor
David Robert Jaap
Samuel George Gibson
Simon Nicholas Thorn
Robert Gilfillan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT1100769E publication Critical patent/PT1100769E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
PT99939419T 1998-07-31 1999-07-26 Derivado do acido aminometilcarboxilico PT1100769E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98306149 1998-07-31

Publications (1)

Publication Number Publication Date
PT1100769E true PT1100769E (pt) 2003-04-30

Family

ID=8234975

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99939419T PT1100769E (pt) 1998-07-31 1999-07-26 Derivado do acido aminometilcarboxilico

Country Status (28)

Country Link
US (1) US6410592B1 (pt)
EP (1) EP1100769B1 (pt)
JP (1) JP4290340B2 (pt)
KR (1) KR100640031B1 (pt)
CN (1) CN1191232C (pt)
AR (1) AR049670A1 (pt)
AT (1) ATE228995T1 (pt)
AU (1) AU762759B2 (pt)
BR (1) BR9912621A (pt)
CA (1) CA2337041C (pt)
CO (1) CO5080746A1 (pt)
CZ (1) CZ301620B6 (pt)
DE (1) DE69904335T2 (pt)
DK (1) DK1100769T3 (pt)
ES (1) ES2189462T3 (pt)
HK (1) HK1035525A1 (pt)
HU (1) HUP0102766A3 (pt)
ID (1) ID26978A (pt)
IL (1) IL140358A0 (pt)
NO (1) NO327756B1 (pt)
NZ (1) NZ509568A (pt)
PL (1) PL198041B1 (pt)
PT (1) PT1100769E (pt)
RU (1) RU2225389C2 (pt)
SK (1) SK286474B6 (pt)
TR (1) TR200100270T2 (pt)
TW (1) TW555757B (pt)
WO (1) WO2000007978A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
DE102004030099A1 (de) * 2004-06-22 2006-01-12 Grünenthal GmbH Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren
AU2006205796B2 (en) * 2005-01-14 2010-09-02 Merck Sharp & Dohme B.V. Glycine reuptake inhibitors for treating drug and alcohol dependence
JP5438975B2 (ja) * 2006-01-06 2014-03-12 サノビオン ファーマシューティカルズ インク テトラロン系モノアミン再取り込み阻害剤
CA2703497A1 (en) * 2007-11-06 2009-05-14 N.V. Organon A method of hormone suppression in humans
AR075442A1 (es) * 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
EP2380595A1 (en) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
US8883839B2 (en) * 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) * 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
EP2739614B1 (en) * 2011-08-05 2017-02-22 AbbVie Deutschland GmbH & Co KG AMINOCHROMANEs, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
KR102021162B1 (ko) 2011-11-01 2019-09-11 메르크 파텐트 게엠베하 유기 전계발광 소자
KR20210124523A (ko) 2011-11-17 2021-10-14 메르크 파텐트 게엠베하 스피로디히드로아크리딘 유도체 및 이의 유기 전계발광 소자용 재료로서의 용도
WO2013072520A1 (en) 2011-11-18 2013-05-23 AbbVie Deutschland GmbH & Co. KG N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
JP6105040B2 (ja) 2012-03-23 2017-03-29 メルク パテント ゲーエムベーハー エレクトロルミネッセンス素子のための9,9’−スピロビキサンテン誘導体
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2015055771A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
AU2014336153A1 (en) 2013-10-17 2016-04-28 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CN104844471B (zh) * 2015-04-21 2017-05-03 苏州远智医药科技有限公司 一种作为dor受体拮抗剂的化合物
US10226442B2 (en) * 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof
AU2018336171B2 (en) 2017-09-22 2023-01-05 Jubilant Epipad LLC Heterocyclic compounds as PAD inhibitors
IL272667B (en) 2017-10-18 2022-09-01 Jubilant Epipad LLC Imidazo-pyridine compounds as pad inhibitors
KR20200085836A (ko) 2017-11-06 2020-07-15 주빌런트 프로델 엘엘씨 Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
US11459338B2 (en) 2017-11-24 2022-10-04 Jubilant Episcribe Llc Heterocyclic compounds as PRMT5 inhibitors
KR20200131845A (ko) 2018-03-13 2020-11-24 주빌런트 프로델 엘엘씨 Pd1/pd-l1 상호작용/활성화 억제제로서의 비사이클릭 화합물
CN110003160B (zh) * 2019-05-14 2022-10-11 贵州中医药大学 一种蛇床子素腙类/酰腙类/磺酰腙类衍生物及其制备方法以及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5657157A (en) * 1995-06-23 1997-08-12 Sdl, Inc. Semiconductor optical amplifying media with reduced self-focusing
CN1130346C (zh) * 1995-09-29 2003-12-10 意大利葛兰素惠尔康股份公司 作为nmda拮抗剂的四氢喹啉类化合物
WO1997045423A1 (en) * 1996-05-31 1997-12-04 Trophix Neuroscience Inc. Pharmaceutical for treating of neurological and neuropsychiatric disorders
SK285854B6 (sk) 1996-05-31 2007-09-06 Allelix Neuroscience Inc. Substituovaný amín, spôsoby jeho prípravy a použitie, farmaceutický prostriedok a jeho použitie

Also Published As

Publication number Publication date
JP2002522412A (ja) 2002-07-23
NO327756B1 (no) 2009-09-14
CN1191232C (zh) 2005-03-02
JP4290340B2 (ja) 2009-07-01
DE69904335D1 (en) 2003-01-16
PL198041B1 (pl) 2008-05-30
SK286474B6 (sk) 2008-11-06
KR100640031B1 (ko) 2006-10-31
CO5080746A1 (es) 2001-09-25
HUP0102766A3 (en) 2002-11-28
SK1492001A3 (en) 2001-08-06
NZ509568A (en) 2003-05-30
DE69904335T2 (de) 2003-10-09
BR9912621A (pt) 2001-04-24
RU2225389C2 (ru) 2004-03-10
AU762759B2 (en) 2003-07-03
ID26978A (id) 2001-02-22
CN1309631A (zh) 2001-08-22
CZ301620B6 (cs) 2010-05-05
EP1100769A1 (en) 2001-05-23
DK1100769T3 (da) 2003-03-24
KR20010072137A (ko) 2001-07-31
TR200100270T2 (tr) 2001-05-21
AU5372499A (en) 2000-02-28
NO20010514L (no) 2001-01-30
US6410592B1 (en) 2002-06-25
AR049670A1 (es) 2006-08-30
CA2337041C (en) 2009-05-26
IL140358A0 (en) 2002-02-10
EP1100769B1 (en) 2002-12-04
NO20010514D0 (no) 2001-01-30
ATE228995T1 (de) 2002-12-15
ES2189462T3 (es) 2003-07-01
CA2337041A1 (en) 2000-02-17
CZ2001398A3 (cs) 2001-07-11
HK1035525A1 (en) 2001-11-30
PL345794A1 (en) 2002-01-02
WO2000007978A1 (en) 2000-02-17
HUP0102766A2 (hu) 2001-12-28
TW555757B (en) 2003-10-01

Similar Documents

Publication Publication Date Title
PT1100769E (pt) Derivado do acido aminometilcarboxilico
PT1077957E (pt) Derivados do acido oxi-iminoalcanoico
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
DE69918278D1 (de) Substituierte indolalkansäure
PT1084103E (pt) Novo derivado do acido 3-aril-2-hidroxipropionico (i)
PT977733E (pt) Derivados de acido arilsulfonilamino-hidroxamico
PT1003720E (pt) Derivados de acido ariloxiarilsulfonilamino hidroxamico
PT1084101E (pt) Novo derivado do acido 3-aril-2-hidroxipropionico (iii)
NO20004849D0 (no) Offshoreborings-system
FI980135A0 (fi) Inbyggt system
PT1084102E (pt) Novos derivados do acido 3-aril-propionico e analogos
ATE222877T1 (de) Kommissionieranlage
DE69915677D1 (de) Vordrucksystem
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
DE59909955D1 (de) Brennstoffzumess-system
DE29821471U1 (de) Befestigungssystem
DE29803723U1 (de) Lichtleistensystem
IT1303759B1 (it) Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
FI980824A0 (fi) Behandling av ett datameddelande i ett naetelement i ett datakommunikationsnaet
FI980176A0 (fi) Foerfarande foer avspelning av ett meddelande i en vaexel foer ett telekommunikationsnaet
DE29812609U1 (de) Befestigungssystem
DE59900673D1 (de) Hublade-Bühnensystem
DE59901663D1 (de) Verbindungssystem
BR9508824A (pt) Derivado de ácido imícido
NO982320L (no) Forbindelsessystem